DK167584A - Rekombinant-dna-overfoeringsvektor og hermed transformeret mikroorganisme - Google Patents
Rekombinant-dna-overfoeringsvektor og hermed transformeret mikroorganisme Download PDFInfo
- Publication number
- DK167584A DK167584A DK167584A DK167584A DK167584A DK 167584 A DK167584 A DK 167584A DK 167584 A DK167584 A DK 167584A DK 167584 A DK167584 A DK 167584A DK 167584 A DK167584 A DK 167584A
- Authority
- DK
- Denmark
- Prior art keywords
- recombinant dna
- transfer vector
- dna transfer
- transformed microorganism
- microorganism
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/17—Metallocarboxypeptidases (3.4.17)
- C12Y304/17011—Glutamate carboxypeptidase (3.4.17.11)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
- C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
- C12N15/78—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Pseudomonas
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2468—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1) acting on beta-galactose-glycoside bonds, e.g. carrageenases (3.2.1.83; 3.2.1.157); beta-agarase (3.2.1.81)
- C12N9/2471—Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/485—Exopeptidases (3.4.11-3.4.19)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01023—Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/034—Fusion polypeptide containing a localisation/targetting motif containing a motif for targeting to the periplasmic space of Gram negative bacteria as a soluble protein, i.e. signal sequence should be cleaved
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Management, Administration, Business Operations System, And Electronic Commerce (AREA)
- Time Recorders, Dirve Recorders, Access Control (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB8308483A GB8308483D0 (en) | 1983-03-28 | 1983-03-28 | Secretion of gene products |
Publications (2)
Publication Number | Publication Date |
---|---|
DK167584D0 DK167584D0 (da) | 1984-03-26 |
DK167584A true DK167584A (da) | 1984-09-29 |
Family
ID=10540349
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK167584A DK167584A (da) | 1983-03-28 | 1984-03-26 | Rekombinant-dna-overfoeringsvektor og hermed transformeret mikroorganisme |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0121352B1 (fr) |
JP (1) | JPS6054686A (fr) |
DE (1) | DE3468434D1 (fr) |
DK (1) | DK167584A (fr) |
GB (1) | GB8308483D0 (fr) |
NO (1) | NO841130L (fr) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4925919A (en) * | 1984-04-25 | 1990-05-15 | Roland Mertelsmann | Purified interleukin 2 |
US4853332A (en) * | 1982-10-19 | 1989-08-01 | Cetus Corporation | Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of biologically active proteins |
US4711844A (en) * | 1983-03-09 | 1987-12-08 | Cetus Corporation | Modified signal peptides |
ATE95236T1 (de) * | 1983-04-25 | 1993-10-15 | Chiron Corp | Hybrid-dns-synthesis von reifen insulinaehnlichen wachstumsfaktoren. |
IL71991A (en) * | 1983-06-06 | 1994-05-30 | Genentech Inc | Preparation of human FGI and FGE in their processed form through recombinant AND tranology in prokaryotes |
US4569790A (en) * | 1984-03-28 | 1986-02-11 | Cetus Corporation | Process for recovering microbially produced interleukin-2 and purified recombinant interleukin-2 compositions |
US4908434A (en) * | 1984-04-25 | 1990-03-13 | Sloan-Kettering Institute For Cancer Research | Process for preparing purified interleukin-2 |
US4908433A (en) * | 1984-04-25 | 1990-03-13 | Sloan-Kettering Institute For Cancer Research | Uses of interleukin-2 |
US4963495A (en) * | 1984-10-05 | 1990-10-16 | Genentech, Inc. | Secretion of heterologous proteins |
US4569794A (en) * | 1984-12-05 | 1986-02-11 | Eli Lilly And Company | Process for purifying proteins and compounds useful in such process |
US4935352A (en) * | 1985-10-21 | 1990-06-19 | Takeda Chemical Industries, Ltd. | Expression vector for animal cell line and use thereof |
JPH07108224B2 (ja) * | 1985-11-07 | 1995-11-22 | 重三 鵜高 | バチルス・ブレビスを用いる遺伝子の発現方法 |
JPH0669377B2 (ja) * | 1985-11-25 | 1994-09-07 | 工業技術院長 | Dna塩基配列およびベクタ− |
JPS6387975A (ja) * | 1986-10-02 | 1988-04-19 | Agency Of Ind Science & Technol | 枯草菌菌株 |
DK175535B1 (da) * | 1987-03-04 | 2004-11-29 | Daiichi Suntory Pharma Co Ltd | Fremgangsmåde til fremstilling af et fysiologisk aktivt cysteinholdigt peptid |
ES2087323T3 (es) * | 1991-02-19 | 1996-07-16 | Takeda Chemical Industries Ltd | Metodo para producir peptidos exentos de cisteina. |
GB9301553D0 (en) * | 1993-01-27 | 1993-03-17 | Univ Wales | Protein synthesis |
GB9415167D0 (en) * | 1994-07-27 | 1994-09-14 | Springer Caroline J | Improvements relating to cancer therapy |
US6410701B1 (en) * | 1995-05-05 | 2002-06-25 | Human Genome Sciences, Inc. | Human neuropeptide receptor |
GB9601640D0 (en) * | 1996-01-26 | 1996-03-27 | Cancer Res Campaign Tech | Ligand directed enzyme prodrug therapy |
US6656718B2 (en) | 2000-07-07 | 2003-12-02 | Cancer Research Technology Limited | Modified carboxypeptidase enzymes and their use |
US9453251B2 (en) | 2002-10-08 | 2016-09-27 | Pfenex Inc. | Expression of mammalian proteins in Pseudomonas fluorescens |
US7153666B2 (en) | 2003-07-17 | 2006-12-26 | General Atomics | Methods and compositions for determination of glycated proteins |
US8187831B2 (en) | 2003-09-19 | 2012-05-29 | General Atomics | Determination of ions using ion-sensitive enzymes |
US7022494B2 (en) | 2003-09-19 | 2006-04-04 | General Atomics | Detection of potassium ions using ion-sensitive enzymes |
MXPA06005705A (es) | 2003-11-21 | 2006-08-23 | Dow Global Technologies Inc | Sistemas de expresion mejorada con secrecion de sistema de sec. |
US8101735B2 (en) | 2004-06-16 | 2012-01-24 | Health Protection Agency | Preparation of protective antigen |
US7355027B2 (en) * | 2004-06-16 | 2008-04-08 | Dynport Vaccine Company Llc | Bacillus anthracis protective antigen |
AU2005269527B2 (en) | 2004-07-26 | 2011-12-01 | Pfenex Inc. | Process for improved protein expression by strain engineering |
AU2007277201B2 (en) | 2006-07-25 | 2014-01-09 | Diazyme Laboratories, Inc. | Methods for assaying percentage of glycated hemoglobin |
US7943385B2 (en) | 2006-07-25 | 2011-05-17 | General Atomics | Methods for assaying percentage of glycated hemoglobin |
CN102517280A (zh) | 2007-01-31 | 2012-06-27 | 菲尼克斯股份有限公司 | 用于提高表达的细菌前导序列 |
US9580719B2 (en) | 2007-04-27 | 2017-02-28 | Pfenex, Inc. | Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins |
CA2685326A1 (fr) | 2007-04-27 | 2008-11-06 | Dow Global Technologies Inc. | Procede pour rapidement cribler des hotes microbiens et identifier certaines souches ayant un rendement et/ou une qualite d'expression des proteines heterologues ameliores |
EP2283149A1 (fr) | 2008-05-13 | 2011-02-16 | General Atomics | Biodétecteur électrochimique pour une détermination directe du pourcentage d'hémoglobine glyquée |
EP2968470B1 (fr) | 2013-03-12 | 2020-10-28 | The General Hospital Corporation | Protéines de substance d'inhibition mullerienne (mis) modifiées et leurs utilisations pour le traitement de maladies |
EP3079712B1 (fr) | 2013-12-11 | 2022-02-02 | The General Hospital Corporation | Utilisation de protéines d'hormone anti-mullerienne (amh) pour la contraception et la préservation de la réserve ovarienne |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NO783724L (no) * | 1977-11-08 | 1979-05-09 | Genentech Inc | Syntetisk dna samt fremgangsmaate til dets fremstilling |
US4506013A (en) * | 1980-10-03 | 1985-03-19 | Eli Lilly And Company | Stabilizing and selecting recombinant DNA host cells |
-
1983
- 1983-03-28 GB GB8308483A patent/GB8308483D0/en active Pending
-
1984
- 1984-03-06 DE DE8484301468T patent/DE3468434D1/de not_active Expired
- 1984-03-06 EP EP19840301468 patent/EP0121352B1/fr not_active Expired
- 1984-03-22 NO NO841130A patent/NO841130L/no unknown
- 1984-03-26 DK DK167584A patent/DK167584A/da not_active IP Right Cessation
- 1984-03-27 JP JP59059287A patent/JPS6054686A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
DE3468434D1 (en) | 1988-02-11 |
GB8308483D0 (en) | 1983-05-05 |
DK167584D0 (da) | 1984-03-26 |
JPS6054686A (ja) | 1985-03-29 |
EP0121352B1 (fr) | 1988-01-07 |
EP0121352A1 (fr) | 1984-10-10 |
NO841130L (no) | 1984-10-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK167584D0 (da) | Rekombinant-dna-overfoeringsvektor og hermed transformeret mikroorganisme | |
DK270982A (da) | Rekombinante dna-klonende vektorer og eukariote og prokariote transformanter deraf | |
DK47285A (da) | Renininhiberende peptider og anvendelsen deraf | |
DK44084D0 (da) | Klonings- og ekspressionsvektor og gaer transformeret dermed | |
DK41484D0 (da) | Beta-phenethanolaminer og deres anvendelse | |
NO833659L (no) | Humant immun-interferonprotein og fremgangsmaate derav | |
DK460782A (da) | Rekombinante dna-klonende vektorpar og transformanter heraf | |
DK454882A (da) | Rekombinante dna-klonende vektorer til anvendelse i streptomyces og dermed beslaegtede organismer | |
DK224985D0 (da) | Peptider, og midler indeholdende peptiderne | |
DK35483D0 (da) | Expressionsvectorer for catechol-2,3-oxygenase, de vundne enzymer og deres anvendelse | |
DK41786A (da) | Stofbloedgoerende og antistatisk rensemiddel | |
NO842682L (no) | Polypeptid og dna-sekvens samt vektor | |
DE3879020D1 (de) | Transfer- und elektrophoreseverfahren. | |
DK158844C (da) | Saltsyrepraeparater og anvendelse heraf | |
DK355286D0 (da) | Toejbloedgoerende og antistatisk vaskemiddel | |
NO833542L (no) | Nytt dna og rekombinantplasmid inneholdende samme | |
DK11584D0 (da) | Rekombinante dna-udtrykkelsesvektorer til anvendelse i bacillus og andre vaertsceller | |
DK451786A (da) | Transglucosidase, fremstilling og anvendelse deraf | |
DK196088A (da) | Rekombinant htlv-iii protein og anvendelse deraf | |
DK433983D0 (da) | Dna og plasmider | |
DK66385A (da) | Rekombinante vektorer til anvendelse i streptomyces og beslaegtede organismer | |
DE3484304D1 (de) | Streptokinase kodierende rekombinante vektoren. | |
DK162607C (da) | Azopigmentpraeparater og deres anvendelse | |
NO900861L (no) | Lysbue oppvarmings og reaksjonssystem | |
DK363786D0 (da) | Hydroquinoliner og anvendelse deraf |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AHB | Application shelved due to non-payment | ||
B1 | Patent granted (law 1993) | ||
PBP | Patent lapsed |